Stockreport

Rhythm Pharmaceuticals Announces Clinical Development Plan of Setmelanotide for Hypothalamic Obesity in Japan [Yahoo! Finance]

Rhythm Pharmaceuticals, Inc.  (RYTM) 
Last rhythm pharmaceuticals, inc. earnings: 3/8 08:12 am Check Earnings Report
US:NASDAQ Investor Relations: ir.rhythmtx.com
PDF -- Significant unmet need with 5,000 to 8,000 patients with hypothalamic obesity estimated to be living in Japan -- BOSTON, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Rhythm P [Read more]